Competitor Analysis: Cardiovascular Peptides

Date: October 9, 2014
Pages: 59
US$ 383.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)

Download PDF Leaflet

Competitor Analysis: Cardiovascular Peptides
Competitor Analysis: Cardiovascular Peptides

The present Competitive Intelligence Report about Cardiovascular Peptides used to treat or prevcent heart failure, myocardial infarction, thrombosis, hypertension, peripheral vascular diseases, hemostasis and wound sealing provides a competitor evaluation in the field of R&D projects with cardiovascular peptides as of October 2014. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of current active projects in research and development of cardiovasuclar peptides. In addition, the report lists company-specific R&D pipelines of cardiovascular peptides. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
2013 Sales of Major Cardiovascular Peptides
Acute Care & Reperfusion Injuries
Heart Failure
Coronary Ischemia & Myocardial Infarction
Cardiometabolic Disease & Atherosclerosis
Peripheral Vascular Disease
Pulmonary Artery Hypertension
Hemostasis, Wound Sealing & Prevention of Thrombosis
Hematologic Diseases
Corporate Cardiovascular Peptide R&D Pipelines
Skip to top

Competitor Analysis: FGF-R Agonists and Antagonists US$ 360.00 Nov, 2009 · 37 pages
Competitor Analysis: Tissue Growth Factors US$ 960.00 Dec, 2009 · 57 pages
Competitor Analysis: Targeted Therapy of Obesity US$ 706.00 Mar, 2011 · 80 pages
Competitor Analysis: FGF-R Agonists and Antagonists US$ 220.00 Nov, 2009 · 20 pages

Ask Your Question

Competitor Analysis: Cardiovascular Peptides
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: